ClinicalTrials HQ

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Recruiting · NCT06184750 · Registry updated 2026-07-27
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE TrialNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast carcinoma, breast carcinoma in situ, breast disorder, breast neoplasm, carcinoma, ductal breast carcinoma in situ, epithelial neoplasm, in situ carcinoma, neoplasm, skin disorderRecruitingPhase 22026-07-27NCT06184750

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
National Cancer Institute (NCI)3015

11 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Brigham and Women's HospitalBostonUnited States511
Case Western Reserve UniversityClevelandUnited States219
Dana-Farber Cancer InstituteBostonUnited States626
Medical University of South CarolinaCharlestonUnited States628
Northwestern UniversityChicagoUnited States727
University of Arizona Cancer Center - Prevention Research ClinicTucsonUnited States7
University of Illinois College of Medicine - ChicagoChicagoUnited States2
University of Kansas Cancer CenterKansas CityUnited States242
University of Michigan Rogel Cancer CenterAnn ArborUnited States186
UT MD Anderson Cancer CenterHoustonUnited States204
Washington University School of MedicineSt LouisUnited States895